Research Article
Volume 11 Issue 4 - 2022
Clinical Profile and Outcome of Pediatric COVID-19 Patients
Faruk Ahmed1*, ANM Shahidul Islam Bhuiyan2, Khondakar Zahirul Hasan1, Mohammad Monir Hossain3 and Mohammad Khairuzzaman4
1Assistant Professor, Department of Pediatrics, Abdul Malek Ukil Medical College (AMUMC), Noakhali, Bangladesh
2Assistant Professor, Department of Pediatrics, Cumilla Medical College, Cumilla, Bangladesh
3Assistant Professor, Department of Pediatrics, M. A. G. Osmani Medical College, Sylhet, Bangladesh
4Assistant Professor, Department of Pediatrics, Cox’s Bazar Medical College, Cox’s Bazar, Bangladesh
*Corresponding Author: Faruk Ahmed, Assistant Professor, Department of Pediatrics, Abdul Malek Ukil Medical College (AMUMC), Noakhali, Bangladesh.
Received: March 23, 2022; Published: March 31, 2022


Introduction: Coronavirus complaint (COVID-19) is a severe acute respiratory contagious complaint coronavirus 2 (SARS-CoV2) infection in children manifests as mild to moderate complaint with low casualty. There's limited information about vulnerability to SARS CoV-2 infection, clinical profile and outgrowth among immunocompromised children in Bangladesh.

Objective: To assess the clinical findings and outcome of paediatric patients with confirmed COVID-19 positivity.

Materials and Methods: This observational study was carried out at the Department of Pediatrics, 250 Bed General Hospital, Gopalganj, Bangladesh from October 2020 to March 2021. The inclusion criteria were Patients aged day 1 to 15 years, and all patients confirmed Covid-19 positive by reverse transcription polymerase chain reaction (RT-PCR). Finally, 56 patients were enrolled in this study. The medical data was analyzed from previously taken questionnaire for each patient. Demographic data, medical history, contact history was included in the questionnaire.

Results: Fifty six patients were included in the study over a period of six months. Mean age was 59.96 ± 43.24 months, 48.2% were male and 51.8% were female. Among fifty six RT-PCR positive cases, thirty seven (66%) were symptomatic and Nineteen (34%) were asymptomatic. Patients got admitted with fever (44.6%), cough (25%), diarrhoea (12.5%), Nausea and vomiting (10.7%). Out of nineteen cases 33.9% were admitted for less than 10 days, 44.6% were admitted for 10 - 14 days and 21.4% were admitted for more than 14 days. Fifteen (26.7%) children were associated with co-morbid conditions like congenital heart disease (10.7%) followed by bronchial asthma, hereditary hemolytic anaemia, adenoid and ROP. 17.8% patient's had leucopenia, 12.5% lymphopenia and raised CRP, patients had, 12.8% patient had neutrophilia. There was Serum Ferritin high in only 7.1% cases. Our study 30.3% patients had normal Chest X-Ray and mild lesion 57.1%, bilateral consolidation 8.9% and 3.5% patchy opacities and six cases eight (14%) cases had positive CRP. Out of the fifty six cases three (5.3%) cases had high S. creatinine level with a mean of 0.47 ± 0.19 mg/dl and seven (12.5%) cases had high S. procalcitonin level with mean procalcitonin level was 0.0656 ± 0.4 ng/ml. Chest X-ray was done in all cases and in all cases these were normal, therefore no HRCT chest was done. Out of all fifty patient 55 patients were improved and discharged. Only one child died in this cohort.

Conclusion: In a significant proportion of children, COVID-19 infection has an asymptomatic course, which contributes greatly to the spread of the complaint. Clinical profile of COVID 19 in children was mild and the outgrowth was good. Fever and cough were the predominant findings of COVID-19 affected children in this study. While COVID-19 causes morbidity similar as storms in the paediatric population, the complaint had a more severe course in children with an underpinning serious complaint and may indeed affect in death.


Keywords: COVID-19; Children; SARS-CoV-2; Outcome


  1. Johns Hopkins University Center for Systems Science and Engineering. Coronavirus COVID-19 global cases.
  2. Jannatul Ferdous., et al. “Clinical Characteristics and Outcomes of Paediatric Patients with Coronavirus Disease (COVID-19): A Single Center Study in Bangladesh”. Bangladesh Journal of Child Health 1 (2021): 15-18.
  3. C Guarneri., et al. “Silent COVID-19: what your skin can reveal”. The Lancet Infectious Diseases1 (2021): 24-25.
  4. D Aygün., et al. “Coronavirus infections in childhood and vaccine studies”. Turkish Archives of Pediatrics 1 (2021): 10-14.
  5. CDC COVID-19 Response Team. “Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020”. Morbidity and Mortality Weekly Report 14 (2020): 422-426.
  6. She J., et al. “COVID-19 epidemic: Disease characteristics in children”. Journal of Medical Virology 7 (2020): 747-754.
  7. Pou C., et al. “The repertoire of maternal anti-viral antibodies in human newborns”. Nature Medicine 4 (2019): 591-596.
  8. Nickbakhsh S., et al. “Virus-virus interactions impact the population dynamics of influenza and the common cold”. Proceedings of the National Academy of Sciences of the United States of America 52 (2019): 27142-27150.
  9. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet10223 (2020): 497-506.
  10. Government of Kerala COVID 19 Clinical Management Report.
  11. Argenzian MG., et al. “Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: Retrospective case series”. British Medical Journal 369 (2020): m1996.
  12. Rivera-Izquierdo MI., et al. “Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study”. PLoS One 6 (2020): e0235107.
  13. Dong Y., et al. “Epidemiology of COVID-19 Among Children in China”. Pediatrics6 (2020): e20200702.
  14. Carmen Lok Tung Ho., et al. “Clinical Characteristics of Children with COVID-19”. AIMS Public Health2 (2020): 258-273.
  15. Zachariah P., et al. “Epidemiology, Clinical Features, and Disease Severity in Patients with Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York”. JAMA Pediatrics10 (2020): e202430.
  16. Lu X., et al. “SARS COV-2 infection in children”. New England Journal of Medicine 17 (2020): 1663-1665.
  17. Schwartz DA and Graham AL. “Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: Lessons from SARS, MERS and other human coronavirus infections”. Viruses2 (2020): 194.
  18. Henry BM., et al. “Laboratory abnormalities in children with novel coronavirus disease 2019”. Clinical Chemistry and Laboratory Medicine 7 (2020): 1135-1138.
  19. Li C., et al. “Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19”. Aging (Albany NY)15 (2020): 15670-15681..
  20. Jonas F Ludvigsson. “Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults”. Acta Paediatrica6 (2020): 1088-1095.
Citation: Faruk Ahmed., et al. “Clinical Profile and Outcome of Pediatric COVID-19 Patients”. EC Paediatrics 11.4 (2022): 133-139.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

February Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the February issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 17, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.